Elso Colleen, Lu Xiaochen, Weisner Patricia A, Thompson Heather L, Skinner Andrea, Carver Ethan, Stubbs Lisa
Genome Biology Division, Lawrence Livermore National Laboratory, Livermore, California.
Genesis. 2013 Sep;51(9):630-46. doi: 10.1002/dvg.22409. Epub 2013 Jul 23.
Pax6 encodes a transcription factor with key roles in the development of the pancreas, central nervous system, and eye. Gene expression is orchestrated by several alternative promoters and enhancer elements that are distributed over several hundred kilobases. Here, we describe a reciprocal translocation, called 1Gso, which disrupts the integrity of transcripts arising from the 5'-most promoter, P0, and separates downstream promoters from enhancers active in pancreas and eye. Despite this fact, 1Gso animals exhibit none of the dominant Pax6 phenotypes, and the translocation complements recessive brain and craniofacial phenotypes. However, 1Gso fails to complement Pax6 recessive effects in lacrimal gland, conjunctiva, lens, and pancreas. The 1Gso animals also express a corneal phenotype that is related to but distinct from that expressed by Pax6 null mutants, and an abnormal density and organization of retinal ganglion cell axons; these phenotypes may be related to a modest upregulation of Pax6 expression from downstream promoters that we observed during development. Our investigation maps the activities of Pax6 alternative promoters including a novel one in developing tissues, confirms the phenotypic consequences of upstream enhancer disruption, and limits the likely effects of the P0 transcript null mutation to recessive abnormalities in the pancreas and specific structures of the eye.
Pax6编码一种转录因子,在胰腺、中枢神经系统和眼睛的发育中起关键作用。基因表达由几个分布在数百千碱基上的可变启动子和增强子元件协调调控。在此,我们描述了一种相互易位,称为1Gso,它破坏了来自最上游启动子P0的转录本的完整性,并将下游启动子与在胰腺和眼睛中活跃的增强子分离。尽管如此,1Gso动物并未表现出任何显性Pax6表型,并且该易位可补充隐性脑和颅面表型。然而,1Gso无法补充Pax6在泪腺、结膜、晶状体和胰腺中的隐性效应。1Gso动物还表现出一种与Pax6基因敲除突变体所表现的角膜表型相关但不同的角膜表型,以及视网膜神经节细胞轴突的密度和组织异常;这些表型可能与我们在发育过程中观察到的下游启动子Pax6表达的适度上调有关。我们的研究绘制了Pax6可变启动子的活性图谱,包括在发育组织中的一个新启动子,证实了上游增强子破坏的表型后果,并将P0转录本无效突变的可能影响限制在胰腺和眼睛特定结构中的隐性异常。